Association of HLA genes with clinical outcomes of ANCA-associated vasculitis

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 8, 2012, Pages 1293-1299

  Chang, Dong Yuan ^a   Luo, Huan ^a   Zhou, Xu jie ^a   Chen, Min ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HLA DRB1 ANTIGEN; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE;

ADOLESCENT; ADULT; AGED; ALLELE; ANCA ASSOCIATED VASCULITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; FEMALE; HAZARD RATIO; HUMAN; KIDNEY FAILURE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CHI-SQUARE DISTRIBUTION; CHINA; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DP BETA-CHAINS; HLA-DR1 ANTIGEN; HLA-DRB1 CHAINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PLASMA EXCHANGE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84864819013     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.13071211     Document Type: Article

References (32)

1. Chen M, Kallenberg CG: The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev 9: A293-A298, 2010
2. Muniain MA, Moreno JC, Gonzalez Cámpora R: Wegener's granulomatosis in two sisters. Ann RheumDis 45: 417-421, 1986
3. Hay EM, BeamanM, Ralston AJ, Ackrill P, Bernstein RM, Holt PJ: Wegener's granulomatosis occurring in siblings. Br J Rheumatol 30: 144-145, 1991
4. Franssen CF, ter Maaten JC, Hoorntje SJ: Brother and sister with myeloperoxidase associated autoimmune disease. Ann Rheum Dis 53: 213, 1994
5. Nowack R, Lehmann H, Flores-Suárez LF, Nanhou A, van der Woude FJ: Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis. Am J Kidney Dis 34: 364-373, 1999
6. Hull CM, Couser WG, Knostman JD: A familial case of P-ANCA glomerulonephritis presenting in a father and daughter. Am J Kidney Dis 35: E23, 2000
7. Brener Z, Cohen L, Goldberg SJ, Kaufman AM: ANCA-associated vasculitis in Greek siblings with chronic exposure to silica. Am J Kidney Dis 38: E28, 2001
8. Heckmann M, Holle JU, Arning L, Knaup S, Hellmich B, Nothnagel M, Jagiello P, Gross WL, Epplen JT, Wieczorek S: The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann Rheum Dis 67: 972-979, 2008
9. Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, Tokunaga K, Hashimoto H: Genetic background of Japanese patients with antineutrophil cytoplasmic antibodyassociated vasculitis: Association of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol 30: 1534-1540, 2003
10. Tsuchiya N, Kobayashi S, Hashimoto H, Ozaki S, Tokunaga K: Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese. Genes Immun 7: 81-84, 2006
11. Gencik M, Borgmann S, Zahn R, Albert E, Sitter T, Epplen JT, Fricke H: Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 117: 412-417, 1999
12. Chen M, Kallenberg CG: New advances in the pathogenesis of ANCA-associated vasculitides. Clin Exp Rheumatol 27[Suppl 52]: S108-S114, 2009
13. Kallenberg CG, Rarok A, Stegeman CA: Genetics of ANCAassociated vasculitides. Cleve Clin J Med 69[Suppl 2]: SII61-SII63, 2002
14. Luo H, Chen M, Yang R, Xu PC, Zhao MH: The association of HLA-DRB1 alleles with antineutrophil cytoplasmic antibodyassociated systemic vasculitis in Chinese patients. HumImmunol 72: 422-425, 2011
15. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, HoffmanGS, HunderGG, Kallenberg CG, Mccluskey RT, Sinico RA, Rees AJ, Van Es LA, Waldherr R, Wiik A: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994
16. Zhao MH, Lockwood CM: A comprehensive method to purify three major ANCA antigens: Proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods 197: 121-130, 1996
17. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1988
18. Luo H, Chen M, Cui Z, Yang R, Xu PC, Zhou XJ, Zhao MH: The association of HLA-DQB1,-DQA1 and-DPB1 alleles with antiglomerular basement membrane (GBM) disease in Chinese patients. BMC Nephrol 12: 21, 2011
19. Chen M, Yu F, Zhang Y, Zhao MH: Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: A study of 426 patients from a single centre. Postgrad Med J 81: 723-727, 2005
20. Chen M, Yu F, Zhang Y, Zhao MH: Antineutrophil cytoplasmic autoantibody-associated vasculitis in older patients. Medicine (Baltimore) 87: 203-209, 2008
21. Jennette JC: Rapidly progressive crescentic glomerulonephritis. Kidney Int 63: 1164-1177, 2003
22. Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66: 605-617, 2007
23. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, AduD: BirminghamVasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87: 671-678, 1994
24. Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289-300, 1995
25. Benjamini Y, Yekutieli D: The control of the false discovery rate in multiple testing under dependency. Ann Stat 29: 1165-1188, 2001
26. Kinikli G, Atesx A, Turgay M, Akay G, Kinikli S, Tokgöz G: HLADRB1 genes and disease severity in rheumatoid arthritis in Turkey. Scand J Rheumatol 32: 277-280, 2003
27. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH: Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31: 355-360, 2002
28. Shindo Y, Inoko H, Yamamoto T, Ohno S: HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 78: 223-226, 1994
29. Ralston DR, Marsh CB, Lowe MP, Wewers MD: Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 100: 1416-1424, 1997
30. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87: 4115-4119, 1990
31. Baschal EE, Aly TA, Babu SR, Fernando MS, Yu L, MiaoD, Barriga KJ, Norris JM, Noble JA, Erlich HA, Rewers MJ, Eisenbarth GS: HLA-DPB1*0402 protects against type 1A diabetes autoimmunity in the highest risk DR3-DQB1*0201/DR4-DQB1*0302 DAISY population. Diabetes 56: 2405-2409, 2007
32. VarneyMD, Valdes AM, Carlson JA, Noble JA, Tait BD, Bonella P, Lavant E, Fear AL, Louey A, Moonsamy P, Mychaleckyj JC, Erlich H; Type 1 Diabetes Genetics Consortium: HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: Analysis of the type 1 diabetes genetics consortium families. Diabetes 59: 2055-2062, 2010